Research
-
Clinician Job Satisfaction After Peer Comparison Feedback
A Secondary Analysis of a Randomized Clinical Trial
Categorized in -
Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share
Using Medicare claims, Schaeffer experts documented US prescribing patterns for originator biologic trastuzumab (Herceptin), a targeted cancer therapy, and five biosimilar entrants since 2019.
Categorized in -
Citizenship status and cost-related nonadherence in the United States, 2017–2021
Noncitizens experience a high burden of cost-related barriers to prescription medications.
Categorized in -
Cross-Sectional Study Examining Household Factors Associated with SARS-CoV-2 Seropositivity in Low-Income Children in L.A.
Food insecure households with low head-of-household education, and at least one household member with type 2 diabetes, had the highest risk of SARS-CoV-2.
Categorized in -
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses
History of cancer was associated with increased likelihood of disability, higher medical spending, and decreased likelihood of employment.
Categorized in -
Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
This cross-sectional study analyzed data from a telehealth OUD treatment provider group currently operating in 32 states to assess the extent of buprenorphine availability at local pharmacies.
Categorized in -
Examining Policies that Inhibit Innovation and Patient Access
Americans have benefited substantially from new medical treatments, and the United States serves as the engine of medical innovation for the world.
-
Does Adding MRI and CSF-Based Biomarkers Improve Cognitive Status Classification Based on Cognitive Performance Questionnaires?
MRI and CSF biomarkers, while important for understanding dementia pathology in clinical research, were not found to substantially improve cognitive status classification based on cognitive status performance.
Categorized in -
Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients
Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality.
Categorized in -
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative
The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.
Categorized in